A doctor may administer magnesium sulfate through an intravenous (IV) injection (into a vein) or an intramuscular (IM) injection (into a muscle). According to a 2021 article, doctors may ...

or intravenous magnesium sulfate (given according to the institutional protocol) from enrollment until 24 hours post partum. High blood pressure was controlled with intravenous hydralazine as needed.

Women who are more than 24 weeks but less than 30 weeks pregnant and in established preterm labour, or having a planned preterm birth within 24 hours, are offered magnesium sulfate, as this medicine ...

In 1906, the treatment of severe tetanus with intrathecal magnesium sulfate was first described. [27] Subsequently, intravenous magnesium has been utilized in both adults and children as an ...

There have been a number of studies to evaluate the usefulness of IV magnesium sulfate (MgSO4) in the treatment of acute exacerbations of asthma, and most have used 1.2-2 g IV over 20 minutes ...

A new report finds that children who receive intravenous (IV) magnesium sulfate to treat refractory asthma are much more likely to be hospitalized than children who did not receive the treatment.

Magnesium sulfate is neuroprotective in preclinical models of stroke and has shown signals of potential efficacy with an acceptable safety profile when delivered early after stroke onset in humans.

Although guidelines recommend the use of IV magnesium sulfate for refractory asthma in pediatric patients, the number of hospitalizations linked to asthma have remained stagnant. In addition ...